Cargando…
Synthesis and Biomedical Potential of Azapeptide Modulators of the Cluster of Differentiation 36 Receptor (CD36)
The innovative development of azapeptide analogues of growth hormone releasing peptide-6 (GHRP-6) has produced selective modulators of the cluster of differentiation 36 receptor (CD36). The azapeptide CD36 modulators curb macrophage-driven inflammation and mitigate atherosclerotic and angiogenic pat...
Autores principales: | Proulx, Caroline, Zhang, Jinqiang, Sabatino, David, Chemtob, Sylvain, Ong, Huy, Lubell, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459725/ https://www.ncbi.nlm.nih.gov/pubmed/32717955 http://dx.doi.org/10.3390/biomedicines8080241 |
Ejemplares similares
-
Azasulfurylpeptide Modulation of CD36-Mediated Inflammation Without Effect on Neovascularization
por: Turcotte, Stéphane, et al.
Publicado: (2018) -
Immunometabolic modulation of retinal inflammation by CD36 ligand
por: Mellal, Katia, et al.
Publicado: (2019) -
A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice
por: Gauvin, Jade, et al.
Publicado: (2023) -
CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits
por: Picard, Emilie, et al.
Publicado: (2010) -
Low-Bone-Mass Phenotype of Deficient Mice for the Cluster of Differentiation 36 (CD36)
por: Kevorkova, Olha, et al.
Publicado: (2013)